SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma.

Cell Death Dis · 2022 · PMC9001737 · PMID 35411037

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the expression level of SLC25A38 did not reach significant difference among tumors with different T stages, the median value of SLC25A38 expression showed a trend of decreasing level of expression with increasing T stage (Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.